Ardsley Advisory Partners’s CVS Health CVS Stock Holding History

Ardsley Advisory Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.14M	Sell	40,000 -45,000	-53%	-$4.02M	0.43%	72
2026 Q1	$6.1M	Hold	85,000	–	–	0.78%	39
2025 Q4	$6.75M	Sell	85,000 -15,000	-15%	-$1.18M	0.74%	49
2025 Q3	$7.54M	Sell	100,000 -10,000	-9%	-$685K	0.93%	39
2025 Q2	$7.59M	Buy	+110,000	New	+$7.21M	1%	31
2019 Q1	–	Sell	-195,000	Closed	-$12.8M	–	135
2018 Q4	$12.8M	Buy	+195,000	New	+$14.6M	3.21%	11
2018 Q1	–	Sell	-7,500	Closed	-$545K	–	150
2017 Q4	$545K	Buy	+7,500	New	+$545K	0.07%	92
2016 Q3	–	Sell	-5,000	Closed	-$479K	–	166
2016 Q2	$479K	Buy	+5,000	New	+$498K	0.08%	88
2016 Q1	–	Sell	-3,500	Closed	-$342K	–	156
2015 Q4	$342K	Hold	3,500	–	–	0.04%	100
2015 Q3	$338K	Sell	3,500 -3,500	-50%	-$368K	0.08%	102
2015 Q2	$734K	Hold	7,000	–	–	0.09%	93
2015 Q1	$722K	Hold	7,000	–	–	0.1%	101
2014 Q4	$674K	Hold	7,000	–	–	0.11%	98
2014 Q3	$557K	Hold	7,000	–	–	0.07%	111
2014 Q2	$528K	Buy	7,000 +2,000	+40%	+$151K	0.07%	147
2014 Q1	$374K	Buy	+5,000	New	+$353K	0.06%	160

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Ardsley Advisory Partners's CVS Position: Q2 2026 in Review

Ardsley Advisory Partners reduced its CVS Health (CVS) stake by 53% in Q2 2026, selling an estimated $4.02M and leaving 40,000 shares worth $4.14M. The position accounts for 0.43% of the portfolio, ranked #72.

Ardsley Advisory Partners first reported a position in CVS in Q1 2014 and has held it in 16 quarters since. The position peaked at $12.8M in Q4 2018. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Ardsley Advisory Partners held 40,000 shares of CVS Health worth $4.14M as of Q2 2026.
Ardsley Advisory Partners sold 45,000 CVS Health shares in Q2 2026, an estimated $4.02M.
CVS Health made up 0.43% of Ardsley Advisory Partners's portfolio in Q2 2026, its #72 holding.
Ardsley Advisory Partners first reported a position in CVS Health in Q1 2014 and has held it in 16 quarters since.
Ardsley Advisory Partners's CVS Health position peaked at $12.8M in Q4 2018.
567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.